DRTS - Alpha Tau Medical Ltd.

QQQ $ 476.19 $ 1.73 (0.36 %)

DIA $ 411.96 $ -0.30 (-0.07 %)

SPY $ 561.01 $ 1.87 (0.33 %)

TLT $ 97.70 $ 0.13 (0.13 %)

GLD $ 232.39 $ 0.71 (0.31 %)

Previous Close

$ 2.26

Open

$ 2.17

Bid

$ 2.19 x 100

Ask

$ 2.30 x 100

Day's Range

$ 2.17 - $ 2.17

52 Week Range

$ 1.75 - $ 3.90

Volume

8,952

Average Volume

Market Cap

157.46M

Beta (5Y Monthly)

$ 1.39

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Alph...
08/20/2024 17:30:49

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

Piper Sandler Reiterates Overweight on Alp...
08/15/2024 18:00:36

Piper Sandler analyst Jason Bednar reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Overweight and maintains $7 price target.

On Wednesday August 14, 2024, Alpha Tau Me...
08/15/2024 13:45:05

Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0...

HC Wainwright & Co. Reiterates Buy on Alph...
06/26/2024 11:07:04

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

Alpha Tau Medical Publishes Pooled Analysi...
06/25/2024 12:37:06

No Severe Long-Term Toxicities With 2-Year Local Recurrence-Free Survival At 77%

HC Wainwright & Co. Reiterates Buy on Alph...
05/22/2024 11:59:58

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

Alpha Tau Medical Q1 EPS $(0.11) Beats $(0...
05/20/2024 20:04:43

Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0...

HC Wainwright & Co. Reiterates Buy on Alph...
05/16/2024 17:38:14

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

Alpha Tau Treats First Patient With Liver ...
05/13/2024 12:34:42

Alpha Tau Presents Preclinical Data Demons...
05/06/2024 12:37:32

- Initial data demonstrates significant reduction in distant pancreatic cancer tumor growth rate starting from three weeks afte...

HC Wainwright & Co. Reiterates Buy on Alph...
03/12/2024 16:19:05

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

Piper Sandler Reiterates Overweight on Alp...
03/08/2024 14:51:47

Piper Sandler analyst Jason Bednar reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Overweight and lowers the price target ...

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
01/10/2024 21:31:09

Expert Ratings for Alpha Tau Medical
12/15/2023 15:01:00

Citigroup Initiates Coverage On Alpha Tau ...
12/15/2023 14:43:25

Citigroup analyst Ashiq Mubarack initiates coverage on Alpha Tau Medical (NASDAQ:DRTS) with a Buy rating and announces Price...

Alpha Tau Announces Interim Results From S...
11/28/2023 13:33:10

- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no pr...

Alpha Tau Submits To Japanese PMDA For Pre...
11/20/2023 13:31:23

Alpha Tau Medical Ltd. ("Alpha Tau") (NASDAQ:DRTS, DRTSW)))), the developer of the innovative alpha-radiation cancer th...

HC Wainwright & Co. Reiterates Buy on Alph...
11/20/2023 11:13:04

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

Analyst Ratings for Alpha Tau Medical
11/17/2023 18:00:22

Piper Sandler Maintains Overweight on Alph...
11/17/2023 17:15:23

Piper Sandler analyst Jason Bednar maintains Alpha Tau Medical (NASDAQ:DRTS) with a Overweight and lowers the price target f...